The Baylor Medicine NTM Infection Program brings together specialists that can help you identify, understand, and manage NTM lung infections. As a leading center for comprehensive NTM care, we aim to ...
BOSTON, June 27, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving ...
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from ...
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
GARDEN CITY, N.Y., April 24, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the ...
BRIDGEWATER, N.J., July 7, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled ...
It’s in the water, embedded in the soil, and lingers in the air we breathe. Every day, we are exposed to microscopic bacteria which often go unnoticed. But then, symptoms appear: chronic cough, ...
Please provide your email address to receive an email when new articles are posted on . Nearly half of patients reported improvements to quality of life compared with placebo. Nontuberculous ...
AUSTIN, Texas, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced interim results from OPTIMA, a Phase 2a clinical study evaluating its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback